G Agnelli - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

G Agnelli

Showing results (191-200 of 202) with videos related to

Pageof 21

Sort By:

Heart (British Cardiac Society)|June 19, 2007

Outcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromesO H Dabbous, F A Anderson, J M Gore, et al.

Journal of Thrombosis and Haemostasis : JTH|December 17, 2003

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS studyB I Eriksson, G Agnelli, A T Cohen, et al.

Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 17, 2019

Deep Vein Thrombosis in Europe-Health-Related Quality of Life and MortalityM Monreal, G Agnelli, L H Chuang, et al.

Thrombosis Research|May 20, 2008

Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatranG Agnelli, B I Eriksson, A T Cohen, et al.

Journal of Thrombosis and Haemostasis : JTH|September 26, 2018

Oxygen saturation or respiratory rate to improve risk stratification in hemodynamically stable patients with acute pulmonary embolismC Becattini, M C Vedovati, P Pruszczyk, et al.

International Journal of Clinical Practice|October 7, 2014

Pain management in internal medicine and effects of a standardised educational intervention: the FADOI-DOMINO studyG Civardi, F Zucco, A Valerio, et al.

Journal of Thrombosis and Haemostasis : JTH|August 13, 2003

Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulationM R Taliani, G Agnelli, P Prandoni, et al.

Circulation|July 4, 2001

Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacementA Lee, G Agnelli, H Büller, et al.

Journal of Thrombosis and Haemostasis : JTH|July 6, 2010

PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant gliomaJ R Perry, J A Julian, N J Laperriere, et al.

Journal of Thrombosis and Haemostasis : JTH|November 3, 2010

Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studiesW Saber, T Moua, E C Williams, et al.

Pageof 21

Search research articles

Showing results (191-200 of 202) with videos related to

Sort By:

Pageof 21

Heart (British Cardiac Society)|June 19, 2007

Outcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromesO H Dabbous, F A Anderson, J M Gore, et al.

Journal of Thrombosis and Haemostasis : JTH|December 17, 2003

Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 17, 2019

Deep Vein Thrombosis in Europe-Health-Related Quality of Life and MortalityM Monreal, G Agnelli, L H Chuang, et al.

Thrombosis Research|May 20, 2008

Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatranG Agnelli, B I Eriksson, A T Cohen, et al.

Journal of Thrombosis and Haemostasis : JTH|September 26, 2018

Oxygen saturation or respiratory rate to improve risk stratification in hemodynamically stable patients with acute pulmonary embolismC Becattini, M C Vedovati, P Pruszczyk, et al.

International Journal of Clinical Practice|October 7, 2014

Pain management in internal medicine and effects of a standardised educational intervention: the FADOI-DOMINO studyG Civardi, F Zucco, A Valerio, et al.

Journal of Thrombosis and Haemostasis : JTH|August 13, 2003

Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulationM R Taliani, G Agnelli, P Prandoni, et al.

Circulation|July 4, 2001

Journal of Thrombosis and Haemostasis : JTH|July 6, 2010

Journal of Thrombosis and Haemostasis : JTH|November 3, 2010

Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studiesW Saber, T Moua, E C Williams, et al.

Pageof 21